Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
A phase 1/2A clinical study to evaluate the safety, tolerability and efficacy of single and repeated doses of AUP1602-C as topical treatment of diabetic foot ulcers

Proposed period of release:
01/01/2019 to 01/01/2021

Name of the Institute(s) or Company(ies)
Aurealis Oy, Microkatu 1,
70211 Kuopio, Finland;

3. Is the same GMO release planned elsewhere in the Community?

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:

Identity of the GMO:
Lactococcus lactis subsp. Cremoris

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
-Lactococcusl. LactiscremorisAUC1000-

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known